Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Repopulation of cancer stem cells in therapeutic resistance

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.05.16
Views: 1527

Prof Keith Chan - Baylor College of Medicine, Houston, USA

Dr Keith Chan speaks with ecancertv at AACR 2016 about ongoing research to target cancer stem cells.

Cancer stem cells, whose origins are discussed in an interview with Dr Luis Parada here, are steadfastly resistant to traditional therapies, and can repopulate tumour cells in the same way as a healthy body heals a wound. 

This repopulation, Dr Chan reports, can come during the pauses between a patient's therapies, and is infact stimulated by the cell death caused by chemotherapy.

Dr Chan discusses ways to target these stem cells during and before their pluripotent repopulation, and covers potential avenues for further research. 

For more on cancer cell resistance in response to chemotherapy, you can watch an interview with Dr Rafaella Sordella here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation